Abstract
The ideal cell culture model should mimic the cell physiology and the mechanical and the chemical cues that are present in specific tissues and organs, within a convenient high-throughput format. A possible key feature for such models is to recapture the cell polarity, the interactions between cells, and the interactions between the cells and the elastic extracellular matrix (ECM) by orienting the cells in a three-dimensional (3D) matrix. A common method to create 3D cell environments is to let the cells aggregate into spheroids with a diameter of around 200 μm. A major challenge for 3D cell cultures is to perform quick and easy imaging of the dense cell population, especially noninvasively. This protocol explains how to take advantage of the number of cells growing out from cell spheroids over time as a readout of the effect of a drug. The assay is compatible with standard imaging techniques and can be performed noninvasively using light microscopy or as a complement to other fluorescent imaging assays.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bhatia SN, Ingber DE (2014) Microfluidic organs-on-chips. Nat Biotechnol 32(8):760–772
Esch EW, Bahinski A, Huh D (2015) Organs-on-chips at the frontiers of drug discovery. Nat Rev Drug Discov 14(4):248–260
Marx U, Andersson TB, Bahinski A et al (2016) Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX 33(3):272–321
Christoffersson J, van Noort D, Mandenius C-F (2017) Developing organ-on-a-chip concepts using bio-mechatronic design methodology. Biofabrication 9(2):025023
Ma L-D, Wang Y-T, Wang J-R et al (2018) Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids. Lab Chip
Ehrlich A, Tsytkin-Kirschenzweig S, Ioannidis K et al (2018) Microphysiological flux balance platform unravels the dynamics of drug induced steatosis. Lab Chip
Jackman CP, Carlson AL, Bursac N (2016) Dynamic culture yields engineered myocardium with near-adult functional output. Biomaterials 111:66–79
Lemoine MD, Mannhardt I, Breckwoldt K et al (2017) Human iPSC-derived cardiomyocytes cultured in 3D engineered heart tissue show physiological upstroke velocity and sodium current density. Sci. Rep 7(1):5464
Wang L, Tao T, Su W et al (2017) A disease model of diabetic nephropathy in a glomerulus-on-a-chip microdevice. Lab Chip 17(10):1749–1760
DesRochers TM, Suter L, Roth A et al (2013) Bioengineered 3D human kidney tissue, a platform for the determination of nephrotoxicity. PLoS One 8(3):e59219
Caballero D, Blackburn SM, de Pablo M et al (2017) Tumour-vessel-on-a-chip models for drug delivery. Lab Chip 17(22):3760–3771
Toh Y-C, Raja A, Yu H et al (2018) A 3D microfluidic model to recapitulate cancer cell migration and invasion. Bioengineering 5(2):29
Prodanov L, Jindal R, Bale SS et al (2016) Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol. Bioengineering 113(1):241–246
Lanz HL, Saleh A, Kramer B et al (2017) Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform. BMC Cancer 17(1):709
Bergström G, Nilsson K, Mandenius CF et al (2014) Macroporous microcarriers for introducing cells into a microfluidic chip. Lab Chip 14(18):3502–3504
Urich E, Patsch C, Aigner S et al (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep 3:1500
Bell CC, Hendriks DFG, Moro SML et al (2016) Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 6:25187
Bergstrom G, Christoffersson J, Schwanke K et al (2015) Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging. Lab Chip 15(15):3242–3249
Christoffersson J, Bergström G, Schwanke K et al (2016) A microfluidic bioreactor for toxicity testing of stem cell derived 3D cardiac bodies. In: Turksen K (ed) Bioreactors in stem cell biology: methods and protocols. Springer Verlag, London, pp 159–168
Lin R-Z, Chang H-Y (2008) Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 3(9–10):1172–1184
Wrzesinski K, Fey JS (2018) Metabolic reprogramming and the recovery of physiological functionality in 3D cultures in micro-bioreactors. Bioengineering 5(1):22
Materne EM, Tonevitsky AG, Marx U (2013) Chip-based liver equivalents for toxicity testing-organotypicalness versus cost-efficient high throughput. Lab Chip 13(18):3481–3495
Oinonen T, Lindros OK (1998) Zonation of hepatic cytochrome P-450 expression and regulation. Biochem J 329(1):17–35
Frimat J-P, Sisnaiske J, Subbiah S et al (2010) The network formation assay: a spatially standardized neurite outgrowth analytical display for neurotoxicity screening. Lab Chip 10(6):701–709
van der Meer AD, Vermeul K, Poot AA et al (2009) A microfluidic wound-healing assay for quantifying endothelial cell migration. Am J Phys Heart Circ Phys 298(2):H719–H725
Christoffersson J, Meier F, Kempf H et al (2018) A cardiac cell outgrowth assay for evaluating drug compounds using a cardiac spheroid-on-a-chip device. Bioengineering 5(2):36
Halloin C, Coffee M, Manstein F, Zweigerdt R, Production of cardiomyocytes from human pluripotent stem cells by bioreactor technologies, Chapter 5 in Cell-Based Assays Using iPSCs for Drug Development and Testing, Methods in Molecular Biology, vol. 1994, Springer Nature 2019
Kempf H, Olmer R, Kropp C et al (2014) Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture. Stem Cell Reports 3(6):1132–1146
Kempf H, Kropp C, Olmer R et al (2015) Cardiac differentiation of human pluripotent stem cells in scalable suspension culture. Nature Protocol 10(9):1345–1361
Kempf H, Olmer R, Haase A et al (2016) Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells. Nat Commun 7:13602
Christoffersson J, Mandenius C-F (2018) Fabrication of a microfluidic cell culture device using photolithographic and soft lithographic techniques. this volume:xxx–xxx
Acknowledgments
The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under (grant no. 115439), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies. This publication reflects only the author’s views, and neither the IMI JU nor EFPIA nor the European Commission is liable for any use that may be made of the information contained therein.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Christoffersson, J. et al. (2019). Evaluating the Effect of Drug Compounds on Cardiac Spheroids Using the Cardiac Cell Outgrowth Assay. In: Mandenius, CF., Ross, J. (eds) Cell-Based Assays Using iPSCs for Drug Development and Testing. Methods in Molecular Biology, vol 1994. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9477-9_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9477-9_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9476-2
Online ISBN: 978-1-4939-9477-9
eBook Packages: Springer Protocols